Estimated Net Worth
- $15.2 M - $42.7 M
Salary
- Unknown
Financial Disclosure Details - OGE Form 278e (02/29/2024)
Positions Held Outside United States Government
# | Organization | City | Position | To |
---|---|---|---|---|
1 | Trustee | Present | ||
2 | Trustee | Present | ||
3 | Trustee | Present | ||
4 | Trustee | Present |
Employment Assets & Income and Retirement Accounts
# | Description | Value | Income Type | Income Amount |
---|---|---|---|---|
1 | IRA #1 | |||
1.1 | ASML Holding N.V. New York Registry Shares (ASML) | $1,001 - $15,000 | None (or less than $201) | |
1.2 | IHS Holding Limited Ordinary Shares (IHS) | $1,001 - $15,000 | None (or less than $201) | |
1.3 | Inhibrx Inc. Common Stock (INBX) | $1,001 - $15,000 | None (or less than $201) | |
1.4 | JD.com Inc. American Depositary Shares (JD) | $15,001 - $50,000 | None (or less than $201) | |
1.5 | Sea Limited American Depositary Shares each representing one Class A Ordinary Share (SE) | $1,001 - $15,000 | None (or less than $201) | |
1.6 | Viridian Therapeutics Inc. Common Stock (VRDN) | $50,001 - $100,000 | None (or less than $201) | |
2 | IRA #2 | |||
2.1 | PRIMECAP Odyssey Growth Fund (POGRX) | $1,001 - $15,000 | None (or less than $201) | |
2.2 | WasatchEmerging Markets Small Cap Fund Institutional Class Shares (WIEMX) | $100,001 - $250,000 | None (or less than $201) |
Employment Agreements and Arrangements
# | Employer Or Party | City | Status And Terms | Date |
---|---|---|---|---|
Nothing reported in this section |
Sources of Compensation Exceeding $5,000 in a Year
# | Source | City | Duties |
---|---|---|---|
Nothing reported in this section |
Spouse's Employment Assets & Income and Retirement Accounts
# | Description | Value | Type | Amount |
---|---|---|---|---|
1 | IRA #1 | |||
1.1 | Vanguard Total Stock Market Index Fund Admiral Class Shares (VTSAX) | $250,001 - $500,000 | None (or less than $201) | |
1.2 | BlackRock US Government Bond Portfolio Investor A Shares (CIGAX) | $1,001 - $15,000 | None (or less than $201) | |
1.3 | U.S. Brokerage Account (cash) | $1,001 - $15,000 | None (or less than $201) | |
2 | IRA #2 | |||
2.1 | Vanguard Total Stock Market Index Fund Admiral Class Shares (VTSAX) | $15,001 - $50,000 | None (or less than $201) | |
3 | IRA #3 | |||
3.1 | U.S. Brokerage Account (cash) | None (or less than $1,001) | None (or less than $201) | |
4 | IRA #4 | |||
4.1 | Cash (U.S. Bank) | $1,001 - $15,000 | None (or less than $201) |
Other Assets and Income
# | Description | Value | Type | Amount |
---|---|---|---|---|
1 | Brokerage Account #1 | |||
1.1 | ADMA Biologics, Inc. (ADMA) | $100,001 - $250,000 | Capital Gains | $100,001 - $1,000,000 |
1.2 | American International Group, Inc. (AIG) | $15,001 - $50,000 | Dividends | $201 - $1,000 |
1.3 | Amgen Inc. (AMGN) | $50,001 - $100,000 | Dividends | $201 - $1,000 |
1.4 | ASML Holding N.V. New York Registry Shares (ASML) | $100,001 - $250,000 | Dividends | $201 - $1,000 |
1.5 | AstraZeneca PLC American Depositary Shares (AZN) | $100,001 - $250,000 | Dividends | $2,501 - $5,000 |
1.6 | Bristol-Myers Squibb (BMY) | $15,001 - $50,000 | Dividends | $1,001 - $2,500 |
1.7 | Berkshire Hathaway Inc. (BRKB) | $100,001 - $250,000 | None (or less than $201) | |
1.8 | Charter Communications, Inc. (CHTR) | $1,001 - $15,000 | None (or less than $201) | |
1.9 | Cigna Corp. (CI) | $50,001 - $100,000 | Dividends | $1,001 - $2,500 |
Transactions
# | Description | Type | Date | Amount |
---|---|---|---|---|
Nothing reported in this section |
Liabilities
# | Creditor | Amount | Incurred | Term |
---|---|---|---|---|
1 | PNC Bank | $50,001 - $100,000 | 2013 | 15 years |
Gifts and Travel Reimbursements
# | Source Name | City | Description | Value |
---|---|---|---|---|
Nothing reported in this section |
Endnotes
Section | # | Description |
---|---|---|
Filer's Information | 1 | Staff to U.S. Senator Laphonza Butler of California |
Filer's Information | 2 | Staff to U.S. Senator Dianne Feinstein of California |
1 | 3 | Start date is estimated |
6 | 1.63 | I owned stock in BAX worth $15,000 to $50,000 which I sold at a loss in January 2024. |
6 | 1.64 | Sold all shares in 2023 |
6 | 1.65 | Sold all shares in 2023 |
6 | 1.66 | Sold all shares in 2023 |
6 | 1.67 | Sold all shares in 2023 at a loss |
6 | 1.68 | Sold all shares (excepting about $400 worth) in 2023 |
6 | 1.69 | Sold all shares in 2023 |
Do you have information about John Watts that is missing from this database?
Drop us a line at [email protected].